Featured Products

[ux_products show=”featured”]

Featured Categories

[ux_product_categories]

Latest news

Long-Term clinical outcome study of CounterCOVID patients published
February 21, 2022

“Lower mortality rate, better clinical status, and shorter duration of invasive ventilation were observed in [...]

First Patients Enter Clinical Trial of Impentri for COVID-19 ARDS
July 12, 2021

“The Impentri IMI2 consortium are pleased to announce the first patients have been dosed in [...]

CounterCOVID study shows imatinib significantly reduces mortality by 49% in patients with COVID-19
June 21, 2021

Results published on Friday 18 June in The Lancet Respiratory Medicine show that oral imatinib, [...]

Could this cancer drug fight fluid build-up in the lungs of COVID patients?
August 27, 2020

IMPENTRI will look for clinical proof of the benefit of imatinib in Covid-19 acute respiratory [...]

IMI2 Grant awarded to fund clinical study of imatinib in the treatment of COVID-19-associated ARDS
August 24, 2020

CAMBRIDGE, UK AND DUBLIN, IRELAND, May 13 2020 / / — Exvastat (Ireland) Ltd, a [...]

Follow on instagram

Instagram did not return a 200.